Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases
Yelin Jeong, Ah‐Reum Oh, Young Hoon Jung, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2097-2104
Open Access | Times Cited: 12

Showing 12 citing articles:

Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer
Aastha Kaushik, Somya Parashar, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102279-102279
Closed Access | Times Cited: 8
Characteristics of the Kelch domain containing (KLHDC) subfamily and relationships with diseases
Courtney Pilcher, Paula Armina V. Buco, Jia Q. Truong, et al.
FEBS Letters (2025)
Open Access
Application of DELs for E3 Ligase Ligand Discovery and Targeted Protein Degradation
Marie L. Malone, Nicholas A. Sanchez, Shimin Hu, et al.
Royal Society of Chemistry eBooks (2025), pp. 134-156
Closed Access
Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access
The Dual Nature of KLHL Proteins: From Cellular Regulators to Disease Drivers
Verdiana Di Giulio, Angelo Canciello, Erminia Carletti, et al.
European Journal of Cell Biology (2025) Vol. 104, Iss. 2, pp. 151483-151483
Open Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
E3 ubiquitin ligase ANKIB1 attenuates antiviral immune responses by promoting K48-linked polyubiquitination of MAVS
Wei Liu, Cui Yuan, Buwen Fu, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114687-114687
Open Access | Times Cited: 2
Gut microbiota-derived indole-3-propionic acid alleviates diabetic kidney disease through its mitochondrial protective effect via reducing ubiquitination mediated-degradation of SIRT1
Yan Zeng, Man Guo, Qi Wu, et al.
Journal of Advanced Research (2024)
Open Access
Ubiquitination Insight from Spinal Muscular Atrophy—From Pathogenesis to Therapy: A Muscle Perspective
Alfonso Bolado‐Carrancio, O. Tapia, José C. Rodríguez‐Rey
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8800-8800
Open Access
Legionella pneumophila , a Rosetta stone to understanding bacterial pathogenesis
Katerina A. Romanov, Tamara J. O’Connor
Journal of Bacteriology (2024)
Closed Access
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation
F Bordin, Gloria Terriaca, Adriano Apostolico, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer
Chih-Chieh Tu, Tsung‐Han Hsieh, Cheng‐Ying Chu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 12
Open Access
Page 1

Scroll to top